En direct

Les mitochondries nouvelles cibles thérapeutiques potentielles dans le cancer du pancréas -

Jul 2019 Genes, chromosomes & cancer

Targeted molecular characterization shows differences between primary and secondary myelofibrosis.

Auteurs

Courtier F, Garnier S, Carbuccia N, Guille A, Adélaide J, Chaffanet M, Hirsch P, Paz DL, Slama B, Vey N, Ugo V, Delhommeau F, Rey J, Birnbaum D, Murati A

Résumé

In BCR-ABL1-negative myeloproliferative neoplasms, myelofibrosis (MF) is either primary (PMF) or secondary (SMF) to polycythemia vera or essential thrombocythemia. MF is characterized by an increased risk of transformation to acute myeloid leukemia (AML) and a shortened life expectancy.

Lire l‘article